Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03371017
What this trial is testing

The Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Hoffmann-La Roche 595
Not applicableNo Longer AvailableNCT04087876
What this trial is testing

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Who this might be right for
Intrahepatic Cholangiocarcinoma
Basilea Pharmaceutica
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Study completedNCT00166881
What this trial is testing

Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin

Who this might be right for
Gastric Cancer
National Taiwan University Hospital 29
Not applicableActive Not RecruitingNCT05817604
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)

Who this might be right for
Kidney NeoplasmRenal CancerInoperable Disease+2 more
Consorci Sanitari de Terrassa 60
Testing effectiveness (Phase 2)Study completedNCT00134433
What this trial is testing

Endothelial Modulation for Angiogenic Therapy

Who this might be right for
Coronary Artery Disease
Ottawa Heart Institute Research Corporation 20
Testing effectiveness (Phase 2)Study completedNCT00023673
What this trial is testing

Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 63
Not applicableEnded earlyNCT01617980
What this trial is testing

Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
German Cancer Research Center 4
Testing effectiveness (Phase 2)Study completedNCT00247676
What this trial is testing

An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer

Who this might be right for
Liver NeoplasmsUnresectable Hepatocellular Carcinoma
Pfizer 37
Testing effectiveness (Phase 2)UnknownNCT02762474
What this trial is testing

Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableTemporarily pausedNCT03444948
What this trial is testing

A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Centre hospitalier de l'Université de Montréal (CHUM) 108
Testing effectiveness (Phase 2)Study completedNCT00003017
What this trial is testing

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT07191418
What this trial is testing

Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors

Who this might be right for
Pancreatic Cancer Metastatic to Liver
Roberto Valente 178
Testing effectiveness (Phase 2)Ended earlyNCT02365584
What this trial is testing

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

Who this might be right for
Intestinal Obstruction
Ipsen 43
Testing effectiveness (Phase 2)Study completedNCT00495040
What this trial is testing

Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)UnknownNCT06422858
What this trial is testing

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 37
Testing effectiveness (Phase 2)UnknownNCT03881306
What this trial is testing

DEBOXA for Inoperable NET Liver Metastases

Who this might be right for
Neuroendocrine TumorsNeoplasm MetastasisLiver
Xiangya Hospital of Central South University 60
Testing effectiveness (Phase 2)Ended earlyNCT00975039
What this trial is testing

Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Steba Biotech S.A. 8
Large-scale testing (Phase 3)Enrolling By InvitationNCT07311057
What this trial is testing

Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy

Who this might be right for
SCC - Squamous Cell CarcinomaSCC - Squamous Cell Carcinoma of SkinInoperable Disease
Daryoush Hamidi Alamdari, PhD 20
Large-scale testing (Phase 3)Looking for participantsNCT05654454
What this trial is testing

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Mabscale, LLC 620
Next Page